Logo VIVE Biotech

Contact information

Natalia Elizalde, Directora Desarrollo de Negocio
Paseo Mikeletegi, 81.
San Sebastián
San Sebastián
Areas of activities
  • A. Health Biotechnology
    • Areas of activity
      • Cellular Therapy
      • Gene Therapy
      • Vaccines
    • Therapeutic areas
      • Musculoskeletal system
      • Cardiovascular diseases and circulatory system
      • Genetic and rare diseases
      • Oncology
      • Blood and lymphatic system
      • Central nervous system
  • C. Industrial Biotechnology
    • APIs and green chemistry
    • Cell lines
  • D. Services
    • R&D services
      • Genomics
      • CRO / CMO / SMO

VIVEbiotech is a GMP Contract Development and Manufacturing Organization (CDMO) specialized in the manufacture of Lentiviral vectors.

Moreover, VIVEbiotech has developed Lentisoma´s technology, a non-Integrative Lentiviral replicative episomal lentiviral vector whose main advantage is associated to Safety-related aspects.

Products and services
  • Lentiviral vectors bioprocess development (USP/DSP)
  • Manufacture of lentiviral vectors for preclinical toxicology
  • GMP manufacture of lentiviral vectors for Clinical trials and commercial
  • Manufacturing relates services (analytics development and validation, stability studies, storage...)
  • Collaborative projects for Lentisoma´s technology validation in different therapeutic indications

Currently working for customers based in Europe and USA.

Biotech Industrial

Product / Service Development phase
Bioprocess development and GMP manufacturing of lentiviral vectors Ready for explotation
Other Technologies
Product / Service Development phase
New pseudotyping strategies Ready for explotation
Construct optimization Ready for explotation
Development of more cost-effective gene therapy processes R&D
Stable producer cell lines R&D